Female Contraceptive Market Research Report by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives), by Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female

Female Contraceptive Market Research Report by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives), by Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, and Intra Uterine Contraceptive Devices (IUCDs)), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global Female Contraceptive Market is expected to grow from USD 7,807.19 Million/EUR 6,845.50 Million in 2020 to USD 10,146.68 Million/EUR 8,896.80 by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.38%.

Market Segmentation & Coverage:

This research report categorizes the Female Contraceptive to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Contraceptive Drug, the Female Contraceptive Market studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills further studied across Hormonal Pills and Non-hormonal Pills.

Based on Contraceptive Devices, the Female Contraceptive Market studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, Intra Uterine Contraceptive Devices (IUCDs), Sub-dermal Contraceptive Implants, and Vaginal Rings.

Based on Distribution Channel, the Female Contraceptive Market studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.

Based on Geography, the Female Contraceptive Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Female Contraceptive Market including Allergan plc, Bayer AG, Cipla Limited, HLL Lifecare Limited, Johnson & Johnson, Mankind Pharma, Merck Sharp & Dohme Corp, Mithra Pharmaceuticals S.A., Pfizer Inc., and Reckitt Benckiser Group plc.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Female Contraceptive Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Female Contraceptive Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?
4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?
5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?
6. What are the modes and strategic moves considered suitable for entering the Global Female Contraceptive Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Contraceptive Drug Outlook
3.4. Distribution Channel Outlook
3.5. Contraceptive Devices Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
4.3. Geographic Growth Opportunities
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Global Female Contraceptive Market, By Contraceptive Drug
6.1. Introduction
6.2. Contraceptive Injections
6.3. Contraceptive Pills
6.3.1. Hormonal Pills
6.3.2. Non-hormonal Pills
6.4. Spermicides
6.5. Topical Contraceptives
7. Global Female Contraceptive Market, By Contraceptive Devices
7.1. Introduction
7.2. Contraceptive Patches
7.3. Contraceptive Sponges
7.4. Diaphragms and Caps
7.5. Female Condoms
7.6. Intra Uterine Contraceptive Devices (IUCDs)
7.7. Sub-dermal Contraceptive Implants
7.8. Vaginal Rings
8. Global Female Contraceptive Market, By Distribution Channel
8.1. Introduction
8.2. Clinic
8.3. Hospital Pharmacy
8.4. Independent Pharmacy
8.5. Online Platform
9. Americas Female Contraceptive Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Female Contraceptive Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. Europe, Middle East & Africa Female Contraceptive Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Allergan plc
13.2. Bayer AG
13.3. Cipla Limited
13.4. HLL Lifecare Limited
13.5. Johnson & Johnson
13.6. Mankind Pharma
13.7. Merck Sharp & Dohme Corp
13.8. Mithra Pharmaceuticals S.A.
13.9. Pfizer Inc.
13.10. Reckitt Benckiser Group plc
14. Appendix
14.1. Discussion Guide

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook